| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:5000 |
AGTR2, the type-2 angiotensin II receptor, plays a distinctive role in the renin-angiotensin system by counterbalancing the vasoconstrictive and proliferative effects mediated by its AT1 counterpart. This receptor has garnered significant research interest for its involvement in cardiovascular regulation, tissue remodeling, and cellular differentiation, making it a compelling target for studies exploring therapeutic interventions in hypertension, cardiac fibrosis, and related pathologies.
This recombinant monoclonal antibody, clone 6C7, offers the consistency and reliability that demanding experimental workflows require. Because it is produced from a defined sequence in a controlled expression system, you can expect uniform performance across lots, eliminating the variability that can complicate longitudinal studies or multi-site collaborations. The rabbit IgG format, purified by affinity chromatography, ensures high specificity for your target while minimizing background interference.
Validation by western blot demonstrates robust detection across a diverse panel of human cell lines, including 293T, HepG2, A549, MCF-7, and Jurkat lysates, as well as mouse liver and heart tissues. This cross-species reactivity between human and mouse samples provides flexibility for researchers working with both cell culture models and in vivo systems. The antibody detects a band at the predicted molecular weight of 42 kDa, confirming target specificity. Recommended working dilutions range from 1:500 to 1:5000 for western blot applications, with additional compatibility for ELISA-based detection methods.
Whether you are investigating angiotensin signaling pathways, characterizing receptor expression in cardiovascular tissues, or exploring AGTR2's role in signal transduction networks, this antibody delivers the reproducibility and validated performance essential for generating publication-quality data.
Email: support@cusabio.com
Distributors Worldwide